Eri S Srivatsan

Title(s)Adjunct Professor, Surgery
SchoolMedicine
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Isolation of a cervical cancer tumor suppressor gene
    NIH I01BX000194Apr 1, 2009 - Mar 31, 2013
    Role: Principal Investigator
    PRECISE LOCALIZATION OF A HUMAN TUMOR SUPPRESSOR GENE
    NIH R29CA047206Jan 1, 1989 - Dec 31, 1993
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Enhanced CTLA-4 blockade anti-tumor immunity with APG-157 combination in a murine head and neck cancer. Cancer Med. 2024 May; 13(9):e7212. Shin DS, Basak S, Veena MS, Comin-Anduix B, Bhattacharya A, Dong TS, Ko A, Han P, Jacobs J, Moatamed NA, Avila L, Pellegrini M, Wang M, Srivatsan ES. PMID: 38686626; PMCID: PMC11058674.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    2. Gigaxonin Suppresses Epithelial-to-Mesenchymal Transition of Human Cancer Through Downregulation of Snail. Cancer Res Commun. 2024 03 08; 4(3):706-722. Veena MS, Gahng JJ, Alani M, Ko AY, Basak SK, Liu IY, Hwang KJ, Chatoff JR, Venkatesan N, Morselli M, Yan W, Ali I, Kaczor-Urbanowicz KE, Gowda BS, Frost P, Pellegrini M, Moatamed NA, Wilczynski SP, Bomont P, Wang MB, Shin DS, Srivatsan ES. PMID: 38421310; PMCID: PMC10921914.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    3. EGFR pathway targeting drugs in head and neck cancer in the era of immunotherapy. Biochim Biophys Acta Rev Cancer. 2023 01; 1878(1):188827. Kang JJ, Ko A, Kil SH, Mallen-St Clair J, Shin DS, Wang MB, Srivatsan ES. PMID: 36309124.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    4. In Vitro Effects of Permethrin on Sinonasal Epithelia. OTO Open. 2022 Jul-Sep; 6(3):2473974X221109838. Lee JT, Yang HH, Sanghoon Shin D, Srivatsan E, Basak S. PMID: 35860617; PMCID: PMC9289904.
      View in: PubMed   Mentions:
    5. Cell-Free RNA as a Novel Biomarker for Response to Therapy in Head & Neck Cancer. Front Oncol. 2022; 12:869108. Tosevska A, Morselli M, Basak SK, Avila L, Mehta P, Wang MB, Srivatsan ES, Pellegrini M. PMID: 35600369; PMCID: PMC9121879.
      View in: PubMed   Mentions: 4  
    6. Dysregulation of hsa-miR-34a and hsa-miR-449a leads to overexpression of PACS-1 and loss of DNA damage response (DDR) in cervical cancer. J Biol Chem. 2020 12 11; 295(50):17169-17186. Veena MS, Raychaudhuri S, Basak SK, Venkatesan N, Kumar P, Biswas R, Chakrabarti R, Lu J, Su T, Gallagher-Jones M, Morselli M, Fu H, Pellegrini M, Goldstein T, Aladjem MI, Rettig MB, Wilczynski SP, Shin DS, Srivatsan ES. PMID: 33028635; PMCID: PMC7863911.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    7. A sensitive LC-MS assay using derivatization with boron trifluoride to quantify curcuminoids in biological samples. Anal Biochem. 2020 05 01; 596:113636. Yoon AJ, Wu H, Pan RD, Teter B, Cipolla J, Chang E, Avila LZ, Basak SK, Srivatsan ES, Wang MB, Cole GM, Frautschy SA, Hampton PD, Faull KF. PMID: 32081619; PMCID: PMC10631463.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    8. A randomized, phase 1, placebo-controlled trial of APG-157 in oral cancer demonstrates systemic absorption and an inhibitory effect on cytokines and tumor-associated microbes. Cancer. 2020 04 15; 126(8):1668-1682. Basak SK, Bera A, Yoon AJ, Morselli M, Jeong C, Tosevska A, Dong TS, Eklund M, Russ E, Nasser H, Lagishetty V, Guo R, Sajed D, Mudgal S, Mehta P, Avila L, Srivastava M, Faull K, Jacobs J, Pellegrini M, Shin DS, Srivatsan ES, Wang MB. PMID: 32022261.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    9. Synergistic Activity with NOTCH Inhibition and Androgen Ablation in ERG-Positive Prostate Cancer Cells. Mol Cancer Res. 2017 10; 15(10):1308-1317. Mohamed AA, Tan SH, Xavier CP, Katta S, Huang W, Ravindranath L, Jamal M, Li H, Srivastava M, Srivatsan ES, Sreenath TL, McLeod DG, Srinivasan A, Petrovics G, Dobi A, Srivastava S. PMID: 28607007; PMCID: PMC5626592.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    10. Human papillomavirus in oropharyngeal cancer: The changing face of a disease. Biochim Biophys Acta. 2016 12; 1866(2):141-150. Mallen-St Clair J, Alani M, Wang MB, Srivatsan ES. PMID: 27487173.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCells
    11. Cystatin E/M Suppresses Tumor Cell Growth through Cytoplasmic Retention of NF-κB. Mol Cell Biol. 2016 06 15; 36(12):1776-92. Soh H, Venkatesan N, Veena MS, Ravichandran S, Zinabadi A, Basak SK, Parvatiyar K, Srivastava M, Liang LJ, Gjertson DW, Torres JZ, Moatamed NA, Srivatsan ES. PMID: 27090639; PMCID: PMC4907098.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    12. A review of gigaxonin mutations in giant axonal neuropathy (GAN) and cancer. Hum Genet. 2016 07; 135(7):675-84. Kang JJ, Liu IY, Wang MB, Srivatsan ES. PMID: 27023907.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    13. Liposome encapsulated curcumin-difluorinated (CDF) inhibits the growth of cisplatin resistant head and neck cancer stem cells. Oncotarget. 2015 Jul 30; 6(21):18504-17. Basak SK, Zinabadi A, Wu AW, Venkatesan N, Duarte VM, Kang JJ, Dalgard CL, Srivastava M, Sarkar FH, Wang MB, Srivatsan ES. PMID: 26098778; PMCID: PMC4621906.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansAnimalsCells
    14. p16 Protein and gigaxonin are associated with the ubiquitination of NFκB in cisplatin-induced senescence of cancer cells. J Biol Chem. 2014 Dec 12; 289(50):34921-37. Veena MS, Wilken R, Zheng JY, Gholkar A, Venkatesan N, Vira D, Ahmed S, Basak SK, Dalgard CL, Ravichandran S, Batra RK, Kasahara N, Elashoff D, Fishbein MC, Whitelegge JP, Torres JZ, Wang MB, Srivatsan ES. PMID: 25331947; PMCID: PMC4263890.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    15. One in four individuals of African-American ancestry harbors a 5.5kb deletion at chromosome 11q13.1. Genomics. 2014 Apr; 103(4):276-87. Zainabadi K, Jain AV, Donovan FX, Elashoff D, Rao NP, Murty VV, Chandrasekharappa SC, Srivatsan ES. PMID: 24412158; PMCID: PMC4162346.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    16. Correction: The CD44high Tumorigenic Subsets in Lung Cancer Biospecimens Are Enriched for Low miR-34a Expression. PLoS One. 2013; 8(9). Basak SK, Veena MS, Oh S, Lai C, Vangala S, Elashoff D, Fishbein MC, Sharma S, Rao NP, Rao D, Phan R, Srivatsan ES, Batra RK. PMID: 24116237; PMCID: PMC3790883.
      View in: PubMed   Mentions:    Fields:    
    17. The CD44(high) tumorigenic subsets in lung cancer biospecimens are enriched for low miR-34a expression. PLoS One. 2013; 8(9):e73195. Basak SK, Veena MS, Oh S, Lai C, Vangala S, Elashoff D, Fishbein MC, Sharma S, Rao NP, Rao D, Phan R, Srivatsan ES, Batra RK. PMID: 24019906; PMCID: PMC3760902.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    18. Hyperactivated JNK is a therapeutic target in pVHL-deficient renal cell carcinoma. Cancer Res. 2013 Feb 15; 73(4):1374-85. An J, Liu H, Magyar CE, Guo Y, Veena MS, Srivatsan ES, Huang J, Rettig MB. PMID: 23393199.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimalsCells
    19. Cancer stem cells, microRNAs, and therapeutic strategies including natural products. Cancer Metastasis Rev. 2012 Dec; 31(3-4):733-51. Vira D, Basak SK, Veena MS, Wang MB, Batra RK, Srivatsan ES. PMID: 22752409.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansAnimalsCells
    20. Cellular senescence and tumor suppressor gene p16. Int J Cancer. 2012 Apr 15; 130(8):1715-25. Rayess H, Wang MB, Srivatsan ES. PMID: 22025288; PMCID: PMC3288293.
      View in: PubMed   Mentions: 359     Fields:    Translation:HumansCells
    21. Curcumin treatment suppresses IKKβ kinase activity of salivary cells of patients with head and neck cancer: a pilot study. Clin Cancer Res. 2011 Sep 15; 17(18):5953-61. Kim SG, Veena MS, Basak SK, Han E, Tajima T, Gjertson DW, Starr J, Eidelman O, Pollard HB, Srivastava M, Srivatsan ES, Wang MB. PMID: 21821700; PMCID: PMC3176971.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    22. Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer. 2011 Feb 07; 10:12. Wilken R, Veena MS, Wang MB, Srivatsan ES. PMID: 21299897; PMCID: PMC3055228.
      View in: PubMed   Mentions: 295     Fields:    Translation:HumansAnimals
    23. Curcumin enhances the effect of cisplatin in suppression of head and neck squamous cell carcinoma via inhibition of IKKβ protein of the NFκB pathway. Mol Cancer Ther. 2010 Oct; 9(10):2665-75. Duarte VM, Han E, Veena MS, Salvado A, Suh JD, Liang LJ, Faull KF, Srivatsan ES, Wang MB. PMID: 20937593; PMCID: PMC3004013.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansAnimalsCells
    24. The malignant pleural effusion as a model to investigate intratumoral heterogeneity in lung cancer. PLoS One. 2009 Jun 12; 4(6):e5884. Basak SK, Veena MS, Oh S, Huang G, Srivatsan E, Huang M, Sharma S, Batra RK. PMID: 19536353; PMCID: PMC2697051.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    25. Suppression of interleukin 6 and 8 production in head and neck cancer cells with curcumin via inhibition of Ikappa beta kinase. Arch Otolaryngol Head Neck Surg. 2009 Feb; 135(2):190-7. Cohen AN, Veena MS, Srivatsan ES, Wang MB. PMID: 19221248.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    26. Inactivation of the CYLD deubiquitinase by HPV E6 mediates hypoxia-induced NF-kappaB activation. Cancer Cell. 2008 Nov 04; 14(5):394-407. An J, Mo D, Liu H, Veena MS, Srivatsan ES, Massoumi R, Rettig MB. PMID: 18977328; PMCID: PMC2651888.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansAnimalsCells
    27. Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway. Clin Cancer Res. 2008 Oct 01; 14(19):6228-36. Wang D, Veena MS, Stevenson K, Tang C, Ho B, Suh JD, Duarte VM, Faull KF, Mehta K, Srivatsan ES, Wang MB. PMID: 18829502.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansAnimalsCells
    28. Inactivation of the cystatin E/M tumor suppressor gene in cervical cancer. Genes Chromosomes Cancer. 2008 Sep; 47(9):740-54. Veena MS, Lee G, Keppler D, Mendonca MS, Redpath JL, Stanbridge EJ, Wilczynski SP, Srivatsan ES. PMID: 18506750; PMCID: PMC2974630.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    29. Cisplatin-induced growth arrest of head and neck cancer cells correlates with increased expression of p16 and p53. Arch Otolaryngol Head Neck Surg. 2006 Mar; 132(3):317-26. Yip HT, Chopra R, Chakrabarti R, Veena MS, Ramamurthy B, Srivatsan ES, Wang MB. PMID: 16549753.
      View in: PubMed   Mentions: 18     Fields:    Translation:Cells
    30. Curcumin suppresses growth of head and neck squamous cell carcinoma. Clin Cancer Res. 2005 Oct 01; 11(19 Pt 1):6994-7002. LoTempio MM, Veena MS, Steele HL, Ramamurthy B, Ramalingam TS, Cohen AN, Chakrabarti R, Srivatsan ES, Wang MB. PMID: 16203793.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansAnimalsCells
    31. A 700-kb physical and transcription map of the cervical cancer tumor suppressor gene locus on chromosome 11q13. Genomics. 2005 Jun; 85(6):704-14. Zainabadi K, Benyamini P, Chakrabarti R, Veena MS, Chandrasekharappa SC, Gatti RA, Srivatsan ES. PMID: 15885497.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    32. Homozygous deletions within the 11q13 cervical cancer tumor-suppressor locus in radiation-induced, neoplastically transformed human hybrid cells. Genes Chromosomes Cancer. 2004 Apr; 39(4):277-87. Mendonca MS, Farrington DL, Mayhugh BM, Qin Y, Temples T, Comerford K, Chakrabarti R, Zainabadi K, Redpath JL, Stanbridge EJ, Srivatsan ES. PMID: 14978789.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    33. Fluorescence in situ hybridization for detecting TP16 MTS1/CDK41 gene deletions in squamous cell carcinoma of the head and neck. Cancer Genet Cytogenet. 2003 Feb; 141(1):49-55. Namazie A, Alavi S, Aghamohammadi N, Aghamohammadi M, Calcaterra TC, Wang MB, Srivatsan ES. PMID: 12581898.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    34. Localization of deletion to a 300 Kb interval of chromosome 11q13 in cervical cancer. Oncogene. 2002 Aug 15; 21(36):5631-42. Srivatsan ES, Chakrabarti R, Zainabadi K, Pack SD, Benyamini P, Mendonca MS, Yang PK, Kang K, Motamedi D, Sawicki MP, Zhuang Z, Jesudasan RA, Bengtsson U, Sun C, Roe BA, Stanbridge EJ, Wilczynski SP, Redpath JL. PMID: 12165862.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    35. Mapping of nasopharyngeal carcinoma tumor-suppressive activity to a 1.8-megabase region of chromosome band 11q13. Genes Chromosomes Cancer. 2002 May; 34(1):97-103. Cheng Y, Chakrabarti R, Garcia-Barcelo M, Ha TJ, Srivatsan ES, Stanbridge EJ, Lung ML. PMID: 11921287.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    36. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors. Laryngoscope. 2002 Mar; 112(3):472-81. Namazie A, Alavi S, Olopade OI, Pauletti G, Aghamohammadi N, Aghamohammadi M, Gornbein JA, Calcaterra TC, Slamon DJ, Wang MB, Srivatsan ES. PMID: 12148857.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    37. Interstitial deletion of 11q13 sequences in HeLa cells. Genes Chromosomes Cancer. 2000 Oct; 29(2):157-65. Srivatsan ES, Bengtsson U, Manickam P, Benyamini P, Chandrasekharappa SC, Sun C, Stanbridge EJ, Redpath JL. PMID: 10959095.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    38. Increased expression of transforming growth factor-beta1, acidic fibroblast growth factor, and basic fibroblast growth factor in fetal versus adult fibroblast cell lines. Laryngoscope. 2000 Apr; 110(4):616-9. Lee NJ, Wang SJ, Durairaj KK, Srivatsan ES, Wang MB. PMID: 10764007.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    39. Clinical application of fluorescence in situ hybridization for chromosome 11q13 analysis in head and neck cancer. Laryngoscope. 1999 Jun; 109(6):874-9. Alavi S, Namazie A, Calcaterra TC, Wang MB, Srivatsan ES. PMID: 10369274.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    40. Comparison of growth factor expression in fetal and adult fibroblasts: a preliminary report. Arch Otolaryngol Head Neck Surg. 1999 Jun; 125(6):676-80. Broker BJ, Chakrabarti R, Blynman T, Roesler J, Wang MB, Srivatsan ES. PMID: 10367926.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    41. Detection of chromosome 11q13 amplification in head and neck cancer using fluorescence in situ hybridization. Anticancer Res. 1999 Mar-Apr; 19(2A):925-31. Wang MB, Alavi S, Engstrom M, Lee J, Namazie A, Moatamed F, Srivatsan ES. PMID: 10368635.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    42. Inhibition of cell proliferation in head and neck squamous cell carcinoma cell lines with antisense cyclin D1. Otolaryngol Head Neck Surg. 1998 Dec; 119(6):593-9. Wang MB, Billings KR, Venkatesan N, Hall FL, Srivatsan ES. PMID: 9852531.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    43. Loss of heterozygosity in squamous cell carcinomas of the head and neck defines a tumor suppressor gene region on 11q13. Cancer Genet Cytogenet. 1998 Jul 15; 104(2):124-32. Venugopalan M, Wood TF, Wilczynski SP, Sen S, Peters J, Ma GC, Evans GA, Srivatsan ES. PMID: 9666806.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    44. Deletion mapping of endocrine tumors localizes a second tumor suppressor gene on chromosome band 11q13. Genes Chromosomes Cancer. 1998 Jun; 22(2):130-7. Chakrabarti R, Srivatsan ES, Wood TF, Eubanks PJ, Ebrahimi SA, Gatti RA, Passaro E, Sawicki MP. PMID: 9598800.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    45. Deletion of P15 (MTS2) in head and neck squamous cell carcinomas. J Surg Res. 1998 Jun; 77(1):50-4. Roesler JM, Livingston EH, Srivatsan E, Chang P, Wang MB. PMID: 9698532.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    46. Deletion analysis of the p16/CDKN2 gene in head and neck squamous cell carcinoma using quantitative polymerase chain reaction method. Arch Otolaryngol Head Neck Surg. 1997 Aug; 123(8):863-7. Rawnsley JD, Srivatsan ES, Chakrabarti R, Billings KR, Wang MB. PMID: 9260553.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    47. A transcript map encompassing the multiple endocrine neoplasia type-1 (MEN1) locus on chromosome 11q13. Genomics. 1997 Jun 15; 42(3):405-12. Sawicki M, Arnold E, Ebrahimi S, Duell T, Jin S, Wood T, Chakrabarti R, Peters J, Wan Y, Samara G, Weier HU, Udar N, Passaro E, Srivatsan ES. PMID: 9205112.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    48. A 1.5-megabase physical map encompassing the multiple endocrine neoplasia type-1 (MEN1) locus on chromosome 11q13. Genomics. 1996 Dec 01; 38(2):166-73. Wood TF, Srivatsan ES, Chakrabarti R, Ma GC, Kuan N, Samara GJ, Higgins MJ, Shows TB, Johnson CL, Wan YJ, Passaro EP, Sawicki MP. PMID: 8954798.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    49. Loss of a putative tumor suppressor locus after gamma-ray-induced neoplastic transformation of HeLa x skin fibroblast human cell hybrids. Radiat Res. 1995 Jul; 143(1):34-44. Mendonca MS, Fasching CL, Srivatsan ES, Stanbridge EJ, Redpath JL. PMID: 7597142.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    50. Deletion and translocation of chromosome 11q13 sequences in cervical carcinoma cell lines. Am J Hum Genet. 1995 Mar; 56(3):705-15. Jesudasan RA, Rahman RA, Chandrashekharappa S, Evans GA, Srivatsan ES. PMID: 7887426; PMCID: PMC1801173.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    51. Rearrangement of chromosome band 11q13 in HeLa cells. Anticancer Res. 1994 Sep-Oct; 14(5A):1727-33. Jesudasan RA, Slovak ML, Sen S, Srivatsan ES. PMID: 7847806.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    52. Deletion of chromosome 11 and of 14q sequences in neuroblastoma. Genes Chromosomes Cancer. 1993 May; 7(1):32-7. Srivatsan ES, Ying KL, Seeger RC. PMID: 7688553.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    53. Loss of heterozygosity for alleles on chromosome II in cervical carcinoma. Am J Hum Genet. 1991 Oct; 49(4):868-77. Srivatsan ES, Misra BC, Venugopalan M, Wilczynski SP. PMID: 1680288; PMCID: PMC1683168.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    54. Localization of HeLa cell tumor-suppressor gene to the long arm of chromosome II. Am J Hum Genet. 1989 Oct; 45(4):565-77. Misra BC, Srivatsan ES. PMID: 2577469; PMCID: PMC1683512.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    55. Complete or partial homozygosity of chromosome 13 in primary retinoblastoma. Cancer Res. 1987 Aug 01; 47(15):4189-91. Benedict WF, Srivatsan ES, Mark C, Banerjee A, Sparkes RS, Murphree AL. PMID: 2886215.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    56. Introduction of human chromosome 11 via microcell transfer controls tumorigenic expression of HeLa cells. EMBO J. 1986 Dec 20; 5(13):3461-6. Saxon PJ, Srivatsan ES, Stanbridge EJ. PMID: 2881780; PMCID: PMC1167381.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansCells
    57. Implication of chromosome 11 in the suppression of neoplastic expression in human cell hybrids. Cancer Res. 1986 Dec; 46(12 Pt 1):6174-9. Srivatsan ES, Benedict WF, Stanbridge EJ. PMID: 2877730.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    58. Selective transfer of individual human chromosomes to recipient cells. Mol Cell Biol. 1985 Jan; 5(1):140-6. Saxon PJ, Srivatsan ES, Leipzig GV, Sameshima JH, Stanbridge EJ. PMID: 3982414; PMCID: PMC366688.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansAnimalsCells
    59. Plasmid, phage, and genomic DNA-mediated transfer and expression of prokaryotic and eukaryotic genes in cultured human cells. Cytogenet Cell Genet. 1984; 38(3):227-34. Srivatsan ES, Stanbridge EJ, Saxon PJ, Stambrook PJ, Trill JJ, Tischfield JA. PMID: 6237889.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    Eri's Networks
    Concepts (328)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (25)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (58)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California